The addition of PAPP-A and PlGF to prediction models based on maternal clinical characteristics (diastolic blood pressure, family history of hypertension in parents, history of gestational hypertension in a previous pregnancy, parity, height and weight) markedly improved prediction of gestational hypertension. This evidence concerns the gene PGF and preeclampsia.